Cancer Drugs Fund requires further reform
Reliance on “real world” observational data undermines evidence base for clinical practice.
मुख्य लेखकों: | Grieve, R, Abrams, K, Claxton, K, Goldacre, B, James, N, Nicholl, J, Parmar, M, Parker, C, Sekhon, J, Smeeth, L, Spiegelhalter, D, Sculpher, M |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
BMJ Publishing Group
2016
|
समान संसाधन
-
Huang Shu Yin funded for further study
द्वारा: Kwong Wah, Yit Poh
प्रकाशित: (2017) -
Huang Shu Yin Funded For Further Study
द्वारा: Kwong Wah, Yit Poh
प्रकाशित: (2017) -
MRE in NAFLD: promising but further validation is required
द्वारा: Ryan, J, और अन्य
प्रकाशित: (2018) -
Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
द्वारा: Morrell, L, और अन्य
प्रकाशित: (2018) -
Bladder cancer: issues requiring further research
द्वारा: I. A. Rozhkov, और अन्य
प्रकाशित: (2024-09-01)